SCHOOL OF MEDICINE  |  PITT HOME  |  FIND PEOPLE  |  FIND A DOCTOR AT UPMC

Department of Medicine

Department of Medicine

   Division of Geriatric Medicine

[Return To Index page]
photo Joseph T. Hanlon, PharmD, MS

Health Scientist

Email: jth14@pitt.edu

Phone: 412-864-2507

Contact
Office: 3471 Fifth Ave.
Kaufmann Building, Suite 500
Pittsburgh, PA 15213
 
Phone: 412-864-2507
Fax: 412-692-2370
E-mail: jth14@pitt.edu
Administrative Assistant:
Beth Thomas
Address: 3471 Fifth Ave, Suite 500
Kaufmann Medical Bldg
Pittsburgh, PA 15213
Phone: 412-864-2507
Fax: 412-692-2370
Education and Training
Education
B.S. Pharmacy, Massachusetts College of Pharmacy, 1978
M.S. Pharmacy Practice, University of North Carolina, Chapel Hill, NC, 1981
PharmD Clinical Pharmacy, University of North Carolina, Chapel Hill, NC, 1990
Training
Residency in Pharmacy Practice, Moses H. Cone Hospital, Greensboro, NC, 1980
Post-Doctoral Training in Biometry, Duke University Medical School, 1992
Post-Doctoral Training in Epidemiology, School of Public Health, Univ. of North Carolina, 1992
Research Interest
Dr Hanlon is Professor of Medicine. With support of an NIA K07 leadership award, he created and now co-directs the University’s Geriatric Pharmaceutical Outcomes and Gero-Informatics Research and Training Program. He is also a Health Scientist with both the Center for Health Equity Research and Promotion (CHERP) and the Geriatric Research Education and Clinical Center (GRECC) at the Pittsburgh VA. In addition to these efforts, he serves on the editorial board of several journals, as PI and Co-I on a number of federally-funded grants, and as research mentor for several junior faculty members.
Publications
For my complete bibliography, Click Here.
Selected Publications:
Hanlon, J. T., Cutson, T., Ruby, C. M. Drug-related falls in the elderly. Topics in Geriatric Rehabilitation. 1996; 11: 38-54.
Hanlon, J. T., Fillenbaum, G. G., Kuchibhatla, M., Artz, M. B., Boult, C., Gross, C. R., Garrard, J., Schmader, K. E. Impact of inappropriate drugs use on mortality and decline in functional status in representative community dwelling elders. Medical Care. 2002; 40: 166-76.
Bohannon, A., Hanlon, J. T., Landerman, L. R., Gold, D. T. Relationship between race and other potential risk factors and nonvertebral fractures in community dwelling elderly women. American Journal of Epidemiology. 1999; 149: 1002-9.
Gray, S. I., LaCroix, A.Z., Hanlon, J. T., Penninx, B., Blough, D. K., Leveille, S.G., Artz, M. B., Guralnik, J.M., Buchner, D. Benzodiazepine use and physical disability in community dwelling older adults. Journal of the American Geriatric Society. 2006; 54: 224-230.
Hilmer, S. N., Mager, D.E., Simonsick, E. M., Cao, Y., Ling, S. M., Windham, B. G., Harris, T. B., Hanlon, J.T., Rubin, S. M., Shorr, R. I., Bauer, D. C., Abernethy, D. R. Drug burden index to define the functional burden of medications in older people. Archives of Internal Medicine. 2007; 167: 781-87.
Boudreau, R. M., Hanlon, J.T., Roumani, Y. F., Studenski, S. A., Ruby, C. M., Wright, R. M., Hilmer, S. N., Shorr, R. I., Bauer, D. C., Simonsick, E. M., Newman, A. B. Central nervous system medication use and mobility limitation in community elders: The Health, Aging and Body Composition Study. Pharmacoepidemiology and Drug Safety. 2009; 18(10): 916-22.
Gray, S. L., Boudreau, R. M., Newman, A. B., Studenski, S. A., Shorr, R.I., Bauer, D. C., Simonsick, E. M., Hanlon, J. T. Angiotensin-converting enzyme inhibitor and statin medication use and incident mobility limitation in community older adults. Journal of American Geriatric Society. 2011; 59: 2226-2232.
Peron, E. P., Hanlon, J. T., Gray, S. L. Medication use and functional status decline in older adults: a narrative review. American Journal of Geriatri Pharmacotherapy. 2011; 9: 378-391.
Hanlon, J. T., Schmader, K. E., Semla, T. P. Update of studies on drug-related problems in older adults. Journal of the American Geriatric Society. 2013; 61: 1365-68.
Sponsored Research/Activities
Title: Pittsburgh Older Americans Independence Center PESC
Role: Core Leader
Funding Agency: National Institute of Aging
Grant Number: P30 AG024827
Start Year: 2015
End Year: 2020
Title: Improving Outcomes of UTI in LTC Facilities: The IOU Study
Role: Co-Investigator
Funding Agency: Agency for Healthcare Research and Quality
Grant Number: R18 HS023779
Start Year: 2015
End Year: 2018
Title: Safety of Opioid Use Among Veterans Receiving Care in Multiple Health Systems
Role: Co-Investigator
Funding Agency: VA HSR&D
Grant Number: I01 IIR 14-297
Start Year: 2015
End Year: 2016
Title: Cumulative CNS Medication Dosage and Serious Fall Injuries
Role: Principal Investigator
Grant Number: XNV 72-215
Start Year: 2015
End Year: 2016
Title: Cumulative CNS Medication Dosage and Serious Fall Injuries
Role: Principal Investigator
Funding Agency: The Donaghue Foundation
Start Year: 2015
End Year: 2016
Title: Dual Use of VA-Medicare Drug Benefits and Unsafe Prescribing in Dementia Patients
Role: Co-Investigator
Funding Agency: VA HSR&D
Grant Number: I01 IIR 12-379
Start Year: 2014
End Year: 2017
Title: Resilience to Mobility Impairment: Neural Correlates and Protective Factors
Role: Co-Investigator
Funding Agency: National Institute of Aging
Grant Number: R01 AG037451
Start Year: 2014
End Year: 2016
Title: John A. Hartford Center of Excellence
Role: Co-Investigator
Funding Agency: American Federation for Aging Research
Start Year: 2014
End Year: 2016
Title: Center for Healthcare Organization and Implementation Research
Role: Co-Investigator
Funding Agency: VA HSR&D
Grant Number: Center CIN 13-403
Start Year: 2014
End Year: 2015
Title: To Develop a Systems-Based Approach to Delirium (Delirium Project)
Role: Co-Investigator
Funding Agency: Pittsburgh Foundation
Start Year: 2014
End Year: 2015
Title: Dual Use of Opioids/Glucose Test Strips and Overuse/Hazardous Use of Medications in the Elderly
Role: Co-Investigator
Funding Agency: PBM
Grant Number: PBM 015
Start Year: 2014
End Year: 2014
Title: Prevalence of Potentially Inappropriate Drug-Disease Interactions in Veterans Affairs Community Living Center Patients Using the Updated Beers Criteria
Role: Co-Investigator
Funding Agency: PBM
Grant Number: PBM 012
Start Year: 2012
End Year: 2014
Title: Resilience to Mobility Impairment: Neural Correlates and Protective Factors
Role: Co-Investigator
Funding Agency: National Institute of Aging
Grant Number: R01 AG037451
Start Year: 2011
End Year: 2014
Title: Center for Health Quality Outcomes and Economic Research
Role: Co-Investigator
Funding Agency: VA HSR&D
Grant Number: Admin HFP 90-011
Start Year: 2011
End Year: 2012
Title: UPITT Program for Pharmaceutical Outcomes Research in Aging
Role: Principal Investigator
Funding Agency: National Institute of Aging
Grant Number: K07 AG033174
Start Year: 2009
End Year: 2015
Title: Program for Pharmaceutical Outcomes Research in Aging
Role: Program Director
Funding Agency: National Institute of Aging
Grant Number: K07 AG033174
Start Year: 2009
End Year: 2014
Title: Impact of Medicare Part D on Racial Disparities Treatment and Outcomes
Role: Co-Investigator
Funding Agency: Agency for Healthcare Research and Quality
Grant Number: R01 HS017695
Start Year: 2009
End Year: 2013
Title: Racial Disparities in Older Adults: Impact of Medicare Part D
Role: Principal Investigator
Funding Agency: National Institute of Aging
Grant Number: R01 AG034056
Start Year: 2009
End Year: 2012
Title: Intervention to Reduce Dietary Sodium in Hemodialysis
Role: Co-Investigator
Funding Agency: National Institute of Nursing Research
Grant Number: R01 NR010135
Start Year: 2008
End Year: 2013
Title: Longitudinal Impact of Antihypertensive Polypharmacy on Geriatric Syndromes
Role: Principal Investigator
Funding Agency: National Institute of Aging
Grant Number: R01 AG027017
Start Year: 2006
End Year: 2014
Title: Pittsburgh Older Americans Independence Center-(PEC)
Role: Core Leader
Funding Agency: National Institute of Aging
Grant Number: P30 AG024827
Start Year: 2004
End Year: 2015